Symbol="GALT"
AssetType="Common Stock"
Name="Galectin Therapeutics Inc"
Description="Galectin Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of therapies for fibrotic, cancerous and other diseases. The company is headquartered in Norcross, Georgia."
CIK="1133416"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="88778000"
EBITDA="None"
PERatio="None"
PEGRatio="0"
BookValue="-0.753"
DividendPerShare="0"
DividendYield="0"
EPS="-0.7"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.9"
ReturnOnEquityTTM="-37.28"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.7"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="11"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="207.7"
EVToRevenue="-"
EVToEBITDA="-2.412"
Beta="1.392"
num_52WeekHigh="2.57"
num_52WeekLow="1.02"
num_50DayMovingAverage="1.592"
num_200DayMovingAverage="1.551"
SharesOutstanding="59582000"
DividendDate="None"
ExDividendDate="None"
symbol="GALT"
open="1.49"
high="1.49"
low="1.44"
price="1.46"
volume="27985.00"
latest_trading_day="2023-07-07"
previous_close="1.49"
change="-0.03"
change_percent="-2.0134%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="33"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="71665"
Change_recent_avg="0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.14"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="1119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0152.jpeg"
image_neutral_thumbnail_id_1="522"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_neutral_thumbnail_id_2="586"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_positive_thumbnail_id_1="977"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
